Erin Foff
Fortuna: 11 M $ al 30/06/2026
Fortuna: 11 M $ al 30/06/2026
Erin Pennock Foff is currently Chief Medical Officer at MapLight Therapeutics, Inc. since 2021.
Formerly, Dr. Foff was Executive Director-Clinical Development at ACADIA Pharmaceuticals, Inc. Education includes doctorates from Baylor College of Medicine and Sidney Kimmel Medical College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/07/2026 | 298.901 ( 0,7 % ) | 11 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.